As Vaccine Revenues Flow In, BioNTech Makes Rapid Oncology Push

German Biotech Initiates Multiple IO Programs

shutterstock-264802244
BioNTech is doing a major push into immuno-oncology • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from Earnings

More from Business